Ali Niloufer S, Nanji Kashmira
Family Medicine, The Aga Khan University.
Cureus. 2017 May 29;9(5):e1288. doi: 10.7759/cureus.1288.
Asthma, a major public health issue, is one of the most common diseases affecting millions of population globally. It is a chronic respiratory disease characterized by increased airway inflammation and hyper-responsiveness. Vitamin D is of particular interest in asthma due to its immunomodulatory effects. Serum 25-hydroxyvitamin D is found to be associated with a wide range of pulmonary diseases, including viral and bacterial respiratory infections, asthma, and cancer. Several researches have reported positive associations between vitamin D and asthma. On the other hand, others have reported contrasting effects of vitamin D on asthma. This review provides an examination of current epidemiologic and experimental evidence of a causal association between vitamin D status and asthma or asthma exacerbations, including its probable protective mechanism. Most of the evidence regarding vitamin D and asthma is reported by observational studies. Therefore, results from the experimental trials of vitamin D supplementation are important as they can provide evidence for future recommendations about the significance of vitamin D for asthma. Moreover, the trials can be effective in assessing the correct dosage and safety of vitamin D supplementation when given in diverse age groups such as children, teenagers, and adults for prevention and treatment of asthma.
哮喘是一个重大的公共卫生问题,是影响全球数百万人的最常见疾病之一。它是一种慢性呼吸道疾病,其特征是气道炎症增加和反应性过高。由于维生素D具有免疫调节作用,因此在哮喘研究中备受关注。血清25-羟基维生素D与多种肺部疾病有关,包括病毒和细菌引起的呼吸道感染、哮喘和癌症。多项研究报告了维生素D与哮喘之间的正相关关系。另一方面,也有其他研究报告了维生素D对哮喘的不同影响。本综述对维生素D水平与哮喘或哮喘发作之间因果关系的当前流行病学和实验证据进行了研究,包括其可能的保护机制。关于维生素D和哮喘的大多数证据来自观察性研究。因此,维生素D补充剂的实验性试验结果很重要,因为它们可以为未来关于维生素D对哮喘重要性的建议提供证据。此外,这些试验在评估维生素D补充剂在儿童、青少年和成年人等不同年龄组中用于预防和治疗哮喘时的正确剂量和安全性方面可能会很有效。